KONTAN.CO.ID - JAKARTA. Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths. A lack of data and varying efficacy rates reported for the vaccine from different countries could undermine public trust in the rollout, according to public health experts. Interim data from a late-stage human test of CoronaVac showed it is 65.3% effective, Indonesia's food and drugs authority BPOM said - lower than figures in Brazil and Turkey which have yet to launch mass vaccinations.
Indonesia approves China's Sinovac vaccine as infections surge
KONTAN.CO.ID - JAKARTA. Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths. A lack of data and varying efficacy rates reported for the vaccine from different countries could undermine public trust in the rollout, according to public health experts. Interim data from a late-stage human test of CoronaVac showed it is 65.3% effective, Indonesia's food and drugs authority BPOM said - lower than figures in Brazil and Turkey which have yet to launch mass vaccinations.